Fin Trust Capital Advisors, LLC Aptinyx Inc. Transaction History

Fin Trust Capital Advisors, LLC

  • $525 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$0.38 - $2.58 $38 - $258
-100 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.11 - $3.0 $211 - $300
100 New
100 $0
Q4 2020

Feb 16, 2021
SELL
$2.93 - $4.3 $791 - $1,161
-270 Closed
0 $0
Q3 2020

Nov 10, 2020
BUY
$3.05 - $4.99 $823 - $1,347
270 New
270 $1,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email